New treatment target for #gout #EULAR2023 SEL-212 - 2 drugs one after the other! - tolerogenic nanoparticles containing rapamycin followed by pegadricase -only 50% reponded, but there were pts who didn't respond at all. @RheumNow https://t.co/RXK58piU85